亚太临床试验用品市场 – 行业趋势及 2029 年预测

市场分析与洞察：亚太临床试验用品市场

预计亚太临床试验用品市场将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2022 年至 2029 年的预测期内，该市场将以 9.2% 的复合年增长率增长，预计到 2029 年将达到 10.2135 亿美元。推动临床试验用品市场增长的主要因素是全球临床试验需求的增加、疾病发病率的增加、政府对研发的投资以及个性化医疗等新疗法的开发，从而引领临床试验用品市场在未来增长。

临床试验是一项研究，旨在确定医疗策略、治疗或设备是否安全、有效且对人类有用。这些研究有助于确定哪种医疗方法最适合某些疾病。临床试验为医疗保健决策提供了最佳数据。

临床试验的目的是研究严格的科学标准。这些标准保护患者并有助于产生可靠的研究结果。

临床试验是药物开发的最后一个阶段，这是一个漫长而细致的研究过程，由科学家或研究人员针对特定疾病（无论是药物还是医疗器械）进行。药物开发过程通常始于实验室，科学家首先在实验室中开发和测试与疾病治疗相关的新想法。

亚太临床试验用品市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入来源、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预​​期目标。

Clinical Trial Supplies Market Dynamics

Drivers

• Rising Demand for Clinical Trial Worldwide

The rising demand for clinical trial has been 82% alone in developing countries such as North America, Europe, and Asia. These drugs are available in the market after clinical trial, so all the companies mostly carry out clinical trial depending on the type of drug or device machine. and hence act as a major driver that will result in the expansion of the growth rate of the treatment market.

• Increasing Incidence of Chronic Diseases

The high prevalence of chronic diseases due to the rapidly increasing population and infections among people can be seen globally. These diseases contribute a major role in the clinical trial field for the development of drugs. The drug has to pass all the standard clinical phase to be available before human consumption. Thus, to treat these chronic diseases for humans, the drug has to be safe.

• Government Funds in R&D Investments

The instruments, workforce, medical management in case of harm to researchers, insurance, transportation, ethics committee fee, data processing, and other consumables lead to major cost involvement in clinical trial. Clinical trial are the evaluation of diseases prevention and treatment ideas will further enhance the growth of treatment market.

Opportunities

• Increasing new drug development trial in emerging countries

Clinical trial for drug efficacy is the primary key for drugs development for diseases treatment before launching in the market for human consumption. Additionally, the new drugs have to meet license extensions and international standards before selling and distribution. Increasing the prevalence and incidence of diseases and the rise in the patient’s numbers are the factors leading to emerging trends of clinical trial for drug development in developing countries over the past period.

Also, Governments in emerging markets (China, Brazil, Russia, India, and South Africa) reform public healthcare and grant more accessible access to medicine. These two factors working in unison mean greater freedom for market developments and increased innovation in clinical research in emerging markets.

Restraints/Challenges

Adverse drug reactions are the unwanted or harmful effects that can be experienced after the administration of a drug under normal conditions of use in humans. The drug reactions generally occur in jaundice, anaemia, rashes and lead to a decrease in the white blood cell count, damaged kidney, and nerve injury that caused impaired vision or hearing.

Many of the adverse effects may be ascertained from physical examinations during the clinical phase of testing. Thus, reporting adverse effects during clinical trial is the major leading restraints factor for the supplies market. Despite high time and cost investments for developing biologics and new drugs, it is estimated that lower procedure time and rate for approval of drug is creating a biggest challenge for the market, which may hamper the market growth.

This clinical trial supplies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on clinical trial supplies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In February 2022, Catalent Inc. announced that the company has expanded the capacity for temperature-controlled storage and distribution of clinical supplies across China. This lead to increase in Clinical Supply for optimize development, launch and better treatments in different morbidities as well as secondary packaging capabilities

Asia-Pacific Clinical Trial Supplies Market Scope

Asia-Pacific clinical trial supplies market is categorized based on services, clinical phase, therapeutic uses and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Service

• Manufacturing
• Distribution
• Storage
• Packaging and Labelling

On the basis of services the Asia-Pacific clinical trial supplies market is segmented into manufacturing, distribution, storage, and packaging and labelling.

Clinical Phase

• Phase I
• Phase II
• Phase III
• Phase IV

On the basis of clinical phase the Asia-Pacific clinical trial supplies market is segmented into phase I, phase II, phase III and phase IV.

Therapeutic Uses

• Oncology
• CNS
• Mental Disorders
• Cardiovascular Diseases
• Infectious Diseases 
• Respiratory Diseases
• Blood Disorder
• Dermatology
• Others

On the basis of therapeutic uses, the Asia-Pacific clinical trial supplies market is segmented into oncology, CNS and mental disorders, cardiovascular diseases, infectious disease, respiratory diseases, metabolic disorders, blood disorders, dermatology and others.

End User

• Contract research organization
• Pharmaceutical and biotechnology companies

On the basis of end user, the Asia-Pacific clinical trial supplies market is segmented into contract research organizations and pharmaceutical and biotechnology companies.

Clinical Trial Supplies Market Regional Analysis/Insights

The Asia-Pacific Clinical trial supplies market is further segmented into major countries such as Japan, China, South Korea, India, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, rest of Asia-Pacific.

India dominates the Asia-Pacific clinical trial supplies market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2022-2029. This is due to the increasing patient pool, rising investment in the healthcare sector and growing government support in this region

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Asia-Pacific Clinical Trial Supplies Market Share Analysis

亚太临床试验用品市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对临床试验用品市场的关注有关。

亚太临床试验用品市场的主要知名参与者包括 Movianto (美国)、Sharp (美国)、Thermo Fisher Scientific Inc.,(美国)、Catalent, Inc (美国)、PCI Pharma Services (美国)、Almac Group (英国)、PAREXEL International Corporation (美国)、Bionical Ltd. (英国)、Alium Medical Limited (英国)、MYODERM (英国)、Clinigen Group plc (英国)、Ancillare, LP (美国)、SIRO Clinpharm (印度) CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC. (美国) Biocair (英国) 等。

研究方法：亚太临床试验用品市场

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-27777